Arcutis Director Sells $121,000 Amid ZORYVE Revenue Surge
A biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
Uncover the best credit cards that offer fantastic rewards without an annual fee. Keep more money in your pocket while enjoying benefits.
28,035 articlesA biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
An AI forecast from Claude points to multix gains for XRP, Solana, and Dogecoin by 2026. The predictions hinge on ado...
A major family-office investor has increased its position in Middleby as the company prepares a spin-off. This move o...
A new NRMLA webinar explores how caregiving and intergenerational concerns influence reverse mortgage choices, offeri...
Nvidia has surged on AI-driven demand, but June could bring new momentum—or volatility. This article breaks down the ...
An international investigation ties a fentanyl-linked chinese network tied to a Japan-based crypto scam to a counterf...
Intel stock crashed week as three pressures converged, turning a rally into a sharp pullback. This article breaks dow...
The SEC's updated listing standards could cut the time to a Cardano spot ETF dramatically, using CME Group's Cardano ...
A fresh risk-off wave hits crypto markets as the VIX climbs past 29, pushing ProShares Ultra Ether ETF (ETHT) and Eth...
As CI&T launches into 2026, investors are scanning for momentum, margin resilience, and strategic bets. This deep div...
Lululemon posted a mixed quarter: international sales led growth while the core US market softened. This analysis dig...
When a CEO steps up with a sizable open-market purchase, investors take note. We unpack what McGraw Hill's 22,000-sha...